Greatchina Biomed (est. 2022) is dedicated to replacing permanent implants with fully absorbable solutions to reduce chronic inflammation risks. Our strength lies in the synergy of a leadership team with 20+ years of mastery and a strategic alliance with the Chinese Academy of Sciences (CAS). This has culminated in 62 filed patents.
